Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
15 February 2017
E-001020-17
Question for written answer
to the Commission
Rule 130
Michał Marusik (ENF)

 Subject:  Resolution of 15 December 2016 on the regulation on paediatric medicines (P8_TA(2016)0511)
 Answer(s) 

On 15 December 2016, the European Parliament adopted a resolution on the regulation on paediatric medicines (P8_TA(2016)0511).

In paragraph 11 the European Parliament calls on the Commission ‘(…) to ensure that Member States enact measures to support research into and the development and availability of medicinal products for paediatric use.’

Further to this resolution, what actions to support Member States on this matter has the Commission taken or will it take soon?

Original language of question: PL 
Last updated: 7 March 2017Legal notice